Ads
related to: drug policy for company employeesuslegalforms.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
The policy put out by the United States Department of Labor states it is illegal for employees "to manufacture, distribute, dispense or have in possession prohibited controlled substances" [4] Under the law, any employer in a covered industry such as federal contracting, trucking, or oil and gas must develop and enforce a policy on drug use in ...
Insys Therapeutics Company type Public Traded as Nasdaq: INSY Industry Pharmaceutical Founded 1990 ; 34 years ago (1990) Founder John Kapoor Fate Bankrupt (2019) Headquarters Chandler, Arizona, U.S. Key people Michael Babich (CEO) Products Subsys (fentanyl) Syndros (Tetrahydrocannabinol) Number of employees 343 (2019) Insys Therapeutics was an American specialty pharmaceutical company based in ...
The Act defines an employer to be any "person engaged in a business affecting commerce who has employees, but does not include the United States or any state or political subdivision of a State." The Act applies to employers as diverse as manufacturers, construction companies, law firms, hospitals, charities, labor unions and private schools.
McLellan, who served as deputy director of the White House’s Office of National Drug Control Policy from 2009 to 2011, recalled recently talking to a despairing parent with an opiate-addicted son. The son had been through five residential treatment stays, costing the family more than $150,000.
In the UK, the company provided the drug free for a limited time for certain patients. Subsequently, the hospitals decided to continue to pay for the drug for those patients. UK agencies estimated the cost per quality adjusted life year (QALY) at between £335,000 and £1,274,000—far above the NICE thresholds [ 29 ] of £20,000-£30,000.
Its 10-K statement indicates that a majority of the company's US revenue in 2016 was derived from the sale of prescription pain killers, predominantly opioids. [ 44 ] On June 8, 2017, the U.S. Food and Drug Administration (FDA) released a press statement in which it announced that it requested Endo to withdraw its opioid drug, oxymorphone ...
The focus of the company in its early years was on genetic screens for receptors, aiming to accelerate early stage drug discovery. [14] The company planned to conduct an Initial public offering (IPO) consisting of 31.6% of the company in 2001, with the intention of raising US$64 million and listing on the NASDAQ exchange under the symbol ACAD. [20]
Drug policies are usually aimed at combatting drug addiction or dependence addressing both demand and supply of drugs, as well as mitigating the harm of drug use, and providing medical assistance and treatment. Demand reduction measures include voluntary treatment, rehabilitation, substitution therapy, overdose management, alternatives to ...
Ads
related to: drug policy for company employeesuslegalforms.com has been visited by 100K+ users in the past month